George Scangos

(Dr. George Scangos Ph.D.)

Currently holds positions in Biogen Inc, Vir Biotechnology Inc, Agilent Technologies Inc and Vir Biotechnology Inc

Performance

4.2
Average Return

-12.5%

30 Days

8.2%

90 Days

15.1%

120 Days
Success Rate

50%

30 Days

68%

90 Days

82%

120 Days

Positions

Position Company Period
Chief Executive Officer, Director Biogen Inc July 15, 2010 -
Chief Executive Officer, Director Vir Biotechnology Inc None -
Independent Director Agilent Technologies Inc Sept. 17, 2014 -
President, Chief Executive Officer, Director Vir Biotechnology Inc Jan. 1, 2017 -
Independent Director Exelixis Inc July 15, 2010 - May 20, 2020
Chief Executive Officer, Director Vir Biotechnology Inc July 1, 2010 - Dec. 1, 2016
George Scangos's trades of Vir Biotechnology Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-25 2025-02-24
S Sale
10,056 -1.4%
9.45
USD 95,063 		10,056 -1.4% 9.45 USD 95,063
2025-02-19 2025-02-18
S Sale
10,964 -1.5%
9.81
USD 107,575 		10,964 -1.5% 9.81 USD 107,575
2024-02-26 2024-02-26
PS Planned sale
17,722 -13.6%
11.65
USD 206,522 		17,722 -13.6% 11.65 USD 206,522
2024-02-26 2024-02-22
S Sale
10,028 -7.1%
10.05
USD 100,737 		10,028 -7.1% 10.05 USD 100,737
2024-02-20 2024-02-20
PS Planned sale
16,872 -10.7%
10.22
USD 172,385 		16,872 -10.7% 10.22 USD 172,385
2024-02-20 2024-02-16
S Sale
10,878 -6.5%
10.24
USD 111,386 		10,878 -6.5% 10.24 USD 111,386
2023-02-24 2023-02-24
PS Planned sale
10,880 -6.1%
23.56
USD 256,300 		10,880 -6.1% 23.56 USD 256,300
2023-02-24 2023-02-24
PS Planned sale
4,239 -2.3%
22.74
USD 96,382 		4,239 -2.3% 22.74 USD 96,382
2023-02-24 2023-02-23
S Sale
12,631 -6.4%
25.97
USD 328,065 		12,631 -6.4% 25.97 USD 328,065
2023-02-21 2023-02-21
PS Planned sale
6,474 -3.2%
28.80
USD 186,451 		6,474 -3.2% 28.80 USD 186,451
2023-02-21 2023-02-21
PS Planned sale
11,382 -5.3%
28.02
USD 318,867 		11,382 -5.3% 28.02 USD 318,867
2023-02-21 2023-02-17
S Sale
9,894 -4.4%
25.29
USD 250,199 		9,894 -4.4% 25.29 USD 250,199
2022-02-22 2022-02-18
PS Planned sale
17,726 -13.6%
30.65
USD 543,304 		17,726 -13.6% 30.65 USD 543,304
2022-02-22 2022-02-17
S Sale
10,024 -7.1%
31.93
USD 320,074 		10,024 -7.1% 31.93 USD 320,074
2020-05-20 2020-05-18
US Exelixis Inc (EXEL)
PS Planned sale
75,000 -9.5%
25.96
USD 1,947,000 		75,000 -9.5% 25.96 USD 1,947,000
2020-04-24 2020-04-24
US Exelixis Inc (EXEL)
PS Planned sale
15,000 -2.0%
26.24
USD 393,600 		15,000 -2.0% 26.24 USD 393,600
2020-04-24 2020-04-23
US Exelixis Inc (EXEL)
PS Planned sale
55,700 -6.9%
26.23
USD 1,461,011 		55,700 -6.9% 26.23 USD 1,461,011
2020-04-24 2020-04-23
US Exelixis Inc (EXEL)
PS Planned sale
44,300 -5.2%
25.68
USD 1,137,624 		44,300 -5.2% 25.68 USD 1,137,624
2020-04-22 2020-04-22
US Exelixis Inc (EXEL)
PS Planned sale
4,200 -0.5%
25.05
USD 105,210 		4,200 -0.5% 25.05 USD 105,210
2020-04-22 2020-04-21
US Exelixis Inc (EXEL)
PS Planned sale
5,800 -0.7%
25.04
USD 145,232 		5,800 -0.7% 25.04 USD 145,232
2020-04-22 2020-04-20
US Exelixis Inc (EXEL)
PS Planned sale
5,900 -0.7%
24.70
USD 145,730 		5,900 -0.7% 24.70 USD 145,730
2020-04-22 2020-04-20
US Exelixis Inc (EXEL)
PS Planned sale
25,600 -2.9%
24.07
USD 616,192 		25,600 -2.9% 24.07 USD 616,192
2020-04-22 2020-04-20
US Exelixis Inc (EXEL)
PS Planned sale
18,500 -2.0%
23.39
USD 432,715 		18,500 -2.0% 23.39 USD 432,715
2020-04-17 2020-04-15
US Exelixis Inc (EXEL)
PS Planned sale
25,000 -2.7%
18.31
USD 457,750 		25,000 -2.7% 18.31 USD 457,750
2020-04-09 2020-04-08
US Exelixis Inc (EXEL)
PS Planned sale
7,065 -0.7%
18.35
USD 129,643 		7,065 -0.7% 18.35 USD 129,643
2020-04-09 2020-04-07
US Exelixis Inc (EXEL)
PS Planned sale
16,435 -1.7%
18.25
USD 299,939 		16,435 -1.7% 18.25 USD 299,939
2020-04-02 2020-03-31
US Exelixis Inc (EXEL)
PS Planned sale
1,500 -0.2%
18.06
USD 27,090 		1,500 -0.2% 18.06 USD 27,090
2020-02-21 2020-02-18
US Exelixis Inc (EXEL)
PS Planned sale
50,000 -4.9%
20.73
USD 1,036,500 		50,000 -4.9% 20.73 USD 1,036,500
2020-02-12 2020-02-12
US Exelixis Inc (EXEL)
PS Planned sale
21,000 -2.0%
20.02
USD 420,420 		21,000 -2.0% 20.02 USD 420,420
2020-02-12 2020-02-11
US Exelixis Inc (EXEL)
PS Planned sale
4,000 -0.4%
20.14
USD 80,560 		4,000 -0.4% 20.14 USD 80,560
2020-01-24 2020-01-22
US Exelixis Inc (EXEL)
PS Planned sale
25,000 -2.4%
19.75
USD 493,750 		25,000 -2.4% 19.75 USD 493,750
2020-01-17 2020-01-15
US Exelixis Inc (EXEL)
PS Planned sale
25,000 -2.3%
20.39
USD 509,750 		25,000 -2.3% 20.39 USD 509,750
2019-07-03 2019-07-01
US Exelixis Inc (EXEL)
PS Planned sale
40,000 -3.3%
21.58
USD 863,200 		40,000 -3.3% 21.58 USD 863,200
2019-06-05 2019-06-04
US Exelixis Inc (EXEL)
PS Planned sale
15,000 -1.2%
20.00
USD 300,000 		15,000 -1.2% 20.00 USD 300,000
2019-06-05 2019-06-03
US Exelixis Inc (EXEL)
PS Planned sale
25,000 -2.0%
19.61
USD 490,250 		25,000 -2.0% 19.61 USD 490,250
2019-05-03 2019-05-02
US Exelixis Inc (EXEL)
PS Planned sale
15,000 -1.2%
20.00
USD 300,000 		15,000 -1.2% 20.00 USD 300,000
2019-05-03 2019-05-01
US Exelixis Inc (EXEL)
PS Planned sale
25,000 -2.0%
19.75
USD 493,750 		25,000 -2.0% 19.75 USD 493,750
2019-04-03 2019-04-03
US Exelixis Inc (EXEL)
PS Planned sale
5,000 -0.4%
25.03
USD 125,150 		5,000 -0.4% 25.03 USD 125,150
2019-04-03 2019-04-01
US Exelixis Inc (EXEL)
PS Planned sale
40,000 -3.0%
24.02
USD 960,800 		40,000 -3.0% 24.02 USD 960,800
2019-03-15 2019-03-14
US Exelixis Inc (EXEL)
PS Planned sale
5,000 -0.4%
25.00
USD 125,000 		5,000 -0.4% 25.00 USD 125,000
2019-03-01 2019-03-01
US Exelixis Inc (EXEL)
PS Planned sale
40,000 -2.9%
22.66
USD 906,400 		40,000 -2.9% 22.66 USD 906,400
2019-02-01 2019-02-01
US Exelixis Inc (EXEL)
PS Planned sale
40,000 -2.9%
23.53
USD 941,200 		40,000 -2.9% 23.53 USD 941,200
2019-01-04 2019-01-03
US Exelixis Inc (EXEL)
PS Planned sale
96 -0.0%
20.00
USD 1,920 		96 -0.0% 20.00 USD 1,920
2019-01-04 2019-01-02
US Exelixis Inc (EXEL)
PS Planned sale
39,904 -2.8%
19.64
USD 783,715 		39,904 -2.8% 19.64 USD 783,715
2016-07-22 2016-07-21
US Biogen Inc (BIIB)
PS Planned sale
157 -0.3%
280.00
USD 43,960 		157 -0.3% 280.00 USD 43,960
// ... existing code ...